GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve (Q43664555)

25 November 2017

GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve (English)

1 reference

25 November 2017

1 reference

Brandt A

1

1 reference

25 November 2017

Katschinski M

2

1 reference

25 November 2017

Arnold R

3

1 reference

25 November 2017

Polonsky KS

4

1 reference

25 November 2017

Göke B

5

1 reference

25 November 2017

Byrne MM

6

1 reference

25 November 2017

1 August 2001

1 reference

American Journal of Physiology - Endocrinology and Metabolism

25 November 2017

1 reference

25 November 2017

281

1 reference

25 November 2017

2

1 reference

25 November 2017

E242-7

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

25 November 2017

1 reference

Insulin secretion and clearance during low-dose graded glucose infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

21 January 2018

Glucagon-like peptides

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Characterization of seven C-peptide antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Signal transduction crosstalk in the endocrine system: pancreatic beta-cells and the glucose competence concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Measurement using tracers of steady-state turnover and metabolic clearance of insulin in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Constitution of a biphasic insulin response to glucose in human fetal pancreatic beta-cells with glucagon-like peptide 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Quantitative study of insulin secretion and clearance in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Insulin secretion and clearance. Comparison after oral and intravenous glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E242

10.1152/AJPENDO.2001.281.2.E242

21 January 2018

Identifiers

DOI

0 references

1 reference